These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31483335)

  • 1. Mechanisms of alloimmunization in sickle cell disease.
    Hudson KE; Fasano RM; Karafin MS; Hendrickson JE; Francis RO
    Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease.
    Chang DY; Wankier Z; Arthur CM; Stowell SR
    Presse Med; 2023 Dec; 52(4):104211. PubMed ID: 37981194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis).
    Wong K; Lai WK; Jackson DE
    Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA; Hendrickson JE
    Blood; 2019 Apr; 133(17):1821-1830. PubMed ID: 30808636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
    McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD
    Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease.
    Desai PC; Deal AM; Pfaff ER; Qaqish B; Hebden LM; Park YA; Ataga KI
    Am J Hematol; 2015 Aug; 90(8):691-5. PubMed ID: 25963831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
    Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.